News Will the NHS force doctors to prescribe biosimilars? NHS authorities could begin to use the reimbursement system as a “stick” to ensure doctors prescribe cheaper biosimilar medicines amid varied uptake in different regions.
News Drug price crackdown imminent, says Trump President Donald Trump has issued a fresh threat against pharma, saying a drug price crackdown could be worked in to new healthcare reforms.
News J&J: drug price rises below 10% since 2012 Janssen unit responds to criticism from president Trump over pricing.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Pharma must slash rare disease drug prices - patient organis... More rare disease drugs must also be approved, says EURORDIS.
News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.